Pharmaceutical Filtration Market: Analysis and Forecast to 2023
LONDON, Nov. 15, 2017 /PRNewswire/ -- According to the study, the global pharmaceutical filtration market is likely to grow significantly during the forecast period, due to increasing prevalence of chronic diseases, rising prevalence of cancer, increasing geriatric population and increasing production of biopharmaceuticals and generic drugs. In addition, rising healthcare expenditure leading to increase in research and development spending also contributes to the growth of the overall market. High cost of pharmaceutical filtration and stringent regulatory requirements for validation of filtration process are the key factors restraining the global market growth.
Download the full report: https://www.reportbuyer.com/product/5200520
Insights on market segments
As per the findings of the research, the membrane filter is the largest product category in the global pharmaceutical filtration market. Membrane filter is the microporous film with specific pore size, used for retaining unwanted particles or microorganisms larger than their pore size. Microfiltration has been the largest contributor to the growth of the global market, in terms of revenue, among the various techniques for product filtration. Final product processing has been the largest application area for pharmaceutical filtration, followed by raw material filtration, cell separation, water purification and air purification. Manufacturing-scale of operation has been the largest segment of the global market, based on scale of operation.
North America stands as the largest pharmaceutical filtration market
Geographically, North America has been the largest market for pharmaceutical filtration, with the U.S. being the larger contributor to the regional market, compared to Canada. Increasing prevalence of lifestyle associated and chronic diseases, rising geriatric population and increasing production of biopharmaceuticals are the factors that have been driving the growth of the North American market for pharmaceutical filtration. The U.K. has been the largest contributor to the European market for pharmaceutical filtration, followed by Germany and France. The market is expected to witness the fastest growth in Asia-Pacific during 2017 - 2023, owing to increasing cases of chronic diseases, increasing healthcare expenditure leading to increasing research and development spending and increasing geriatric population.
Increasing prevalence of chronic diseases largely impacts the market
Globally, the increasing prevalence of chronic diseases has been playing a key role in the growth of the pharmaceutical filtration market. The rapidly increasing burden of chronic diseases further compels government organizations and healthcare providers to provide improved facilities for effective disease treatment leading to increased drug launch globally.
Prevalence of chronic diseases is increasing due to alteration in lifestyle and lack of access to preventive care. According to the Centers for Disease Control and Prevention (CDC), in 2012, approximately 117 million people in the U.S. had one or more chronic health conditions. The organization also reported that during 2013 – 2015, 54.4 million U.S. adults were diagnosed with some form of arthritis, rheumatoid arthritis, gout, lupus or fibromyalgia. Moreover, an estimated 78 million Americans aged 18 years or above will be diagnosed with arthritis by 2040.
According to the International Agency for Research on Cancer (IARC), a specialized cancer agency of World Health Organization (WHO) that promotes cancer research, 12.7 million new patients globally were detected with cancer in 2008, and the number is expected to reach 21.4 million by 2030. In addition, according to the WHO, 8.2 million deaths took place globally due to cancer in 2012, out of which 1.6 million were due to lung cancer, while 745,000 deaths resulted from liver cancer and 400,000 deaths were an outcome of esophageal cancer.
The increasing burden of chronic diseases is expected to result in higher death rates and additional economic cost. Thus, several developments have been taking place for efficient disease treatment, leading to increased production of drugs supporting the growth of the pharmaceutical filtration market globally.
Key players in the pharmaceutical filtration market
Some of the key players in the global pharmaceutical filtration market include Merck KGaA, Pall Corporation, GE Healthcare, 3M Company, Parker Hannifin Corporation, Sartorius Stedim Biotech S.A., Eaton Corporation PLC, Graver Technologies, LLC, Amazon Filters Ltd. and Meissner Filtration Products, Inc.
GLOBAL PHARMACEUTICAL FILTRATION MARKET SEGMENTATION
By Product
Membrane Filters
Mixed Cellulose Ester (MCE) Membrane Filters
Coated Cellulose Acetate (CCA) Membrane Filters
Polytetrafluoroethylene (PTFE) Membrane Filters
Nylon Membrane Filters
Polyvinylidene Difluoride (PVDF) Membrane Filters
Others
Prefilters & Depth Media Filters
Cartridge & Capsule Filters
Single-Use Systems
Filter Holders
Filtration Accessories
Others
By Technique
Microfiltration
Ultrafiltration
Nanofiltration
Others
By Application
Final Product Processing
Active Pharmaceutical Ingredient Filtration
Sterile Filtration
Protein Purification
Vaccine and Antibody Processing
Formulation and Filling Solution Filtration
Viral Clearance
Raw Material Filtration
Media and Buffer Filtration
Prefiltration
Bioburden Testing
Cell Separation
Water Purification
Air Purification
By Scale of Operations
Manufacturing-Scale
Pilot-Scale
R&D-Scale
By Geography
North America
The U.S.
Canada
Europe
The U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
Download the full report: https://www.reportbuyer.com/product/5200520
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
https://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
SOURCE ReportBuyer
Share this article